Northern Trust’s Urovant Sciences Ltd. UROV Stock Holding History

Northern Trust’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-53,828	Closed	-$868K	–	4521
2020 Q4	$868K	Sell	53,828 -4,871	-8%	-$60.4K	﹤0.01%	3565
2020 Q3	$548K	Sell	58,699 -371	-0.6%	-$3.29K	﹤0.01%	3586
2020 Q2	$581K	Buy	59,070 +43,920	+290%	+$421K	﹤0.01%	3512
2020 Q1	$140K	Buy	15,150 +450	+3%	+$5.41K	﹤0.01%	3758
2019 Q4	$228K	Buy	14,700 +867	+6%	+$9.4K	﹤0.01%	3748
2019 Q3	$131K	Sell	13,833 -3,331	-19%	-$28.9K	﹤0.01%	3865
2019 Q2	$136K	Buy	17,164 +6,144	+56%	+$50.4K	﹤0.01%	3904
2019 Q1	$111K	Buy	+11,020	New	+$113K	﹤0.01%	3907

Northern Trust's UROV Position: Q1 2021 in Review

Northern Trust sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 53,828 shares — an estimated $868K sold.

Northern Trust first reported a position in UROV in Q1 2019 and held it in 8 quarters. The position peaked at $868K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Northern Trust reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Northern Trust sold 53,828 Urovant Sciences Ltd. shares in Q1 2021, an estimated $868K.
Northern Trust first reported a position in Urovant Sciences Ltd. in Q1 2019 and held it in 8 quarters.
Northern Trust's Urovant Sciences Ltd. position peaked at $868K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Northern Trust's 13F filing for Q1 2021, filed 12 May 2021.